249 related articles for article (PubMed ID: 7039825)
1. Quantitative aspects of drug-mediated tumour promotion in liver and its toxicological implications.
Kunz W; Schaude G; Schwarz M; Tennekes H
Carcinog Compr Surv; 1982; 7():111-25. PubMed ID: 7039825
[No Abstract] [Full Text] [Related]
2. Development of a model to simulate the characteristics of rat liver tumor promotion by phenobarbital.
Stevens FJ; Peraino C
Carcinog Compr Surv; 1982; 7():105-9. PubMed ID: 7066914
[No Abstract] [Full Text] [Related]
3. Properties of incomplete carcinogens and promoters in hepatocarcinogenesis.
Pitot HC; Goldsworthy T; Moran S; Sirica AE; Weeks J
Carcinog Compr Surv; 1982; 7():85-98. PubMed ID: 6802499
[No Abstract] [Full Text] [Related]
4. Analysis of the effects of promoting agents on liver and urinary bladder carcinogenesis in rats.
Ito N; Tatematsu M; Nakanishi K; Tsuda H
Carcinog Compr Surv; 1982; 7():133-7. PubMed ID: 7066916
[No Abstract] [Full Text] [Related]
5. Short-term in vivo initiation/promotion bioassay for hepatocarcinogens.
Ford JO; Pereira MA
J Environ Pathol Toxicol; 1980 Nov; 4(5-6):39-46. PubMed ID: 6111580
[TBL] [Abstract][Full Text] [Related]
6. Initiation and promotion of liver tumorigenesis.
Peraino C
Natl Cancer Inst Monogr; 1981 Dec; (58):55-61. PubMed ID: 7341984
[No Abstract] [Full Text] [Related]
7. The effects of dose and duration of administration on the promotion index of phenobarbital in multistage hepatocarcinogenesis in the rat.
Rizvi TA; Kennan W; Xu YH; Pitot HC
APMIS Suppl; 1988; 2():262-74. PubMed ID: 3179034
[TBL] [Abstract][Full Text] [Related]
8. Lack of phenobarbital-mediated promotion of hepatocarcinogenesis in connexin32-null mice.
Moennikes O; Buchmann A; Romualdi A; Ott T; Werringloer J; Willecke K; Schwarz M
Cancer Res; 2000 Sep; 60(18):5087-91. PubMed ID: 11016633
[TBL] [Abstract][Full Text] [Related]
9. Enhancing effect of chemicals on production of hyperplastic liver nodules induced by n-2-fluorenylacetamide in hepatectomized rats.
Ito N; Tatematsu M; Hirose M; Nakanishi K; Murasaki G
Gan; 1978 Feb; 69(1):143-4. PubMed ID: 416986
[No Abstract] [Full Text] [Related]
10. Enhancement of hepatocarcinogenesis by sequential administration of chemicals: summation versus promotion effects.
Williams GM; Katayama S; Ohmori T
Carcinogenesis; 1981; 2(11):1111-7. PubMed ID: 6119166
[TBL] [Abstract][Full Text] [Related]
11. Reduced carcinogenic effects of aflatoxin in rats given phenobarbitone.
McLean AE; Marshall A
Br J Exp Pathol; 1971 Jun; 52(3):323-9. PubMed ID: 5090689
[TBL] [Abstract][Full Text] [Related]
12. The role of corticoids, adrenalectomy, phenobarbital and pentobarbital in the promotion of DEN-hepatocarcinogenesis.
Bouzahzah B; Pavier D; Barbason H
In Vivo; 1998; 12(4):411-9. PubMed ID: 9706493
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of hepatic preneoplastic lesions as indicators of carcinogenic response.
Bannasch P; Zerban H
IARC Sci Publ; 1992; (116):389-427. PubMed ID: 1428091
[No Abstract] [Full Text] [Related]
14. Prevalidation of a rat liver foci bioassay (RLFB) based on results from 1600 rats: a study report.
Ittrich C; Deml E; Oesterle D; Küttler K; Mellert W; Brendler-Schwaab S; Enzmann H; Schladt L; Bannasch P; Haertel T; Mönnikes O; Schwarz M; Kopp-Schneider A
Toxicol Pathol; 2003; 31(1):60-79. PubMed ID: 12597450
[TBL] [Abstract][Full Text] [Related]
15. The influence of hepatocarcinogens on the central effects of phenobarbital an D-amphetamine.
Gurkalo VK
Neoplasma; 1980; 27(5):543-8. PubMed ID: 7231611
[TBL] [Abstract][Full Text] [Related]
16. Metabolic and morphologic studies of hepatocarcinogenesis in the rat. ANL-7535.
Peraino C; Fry RJ
ANL Rep; 1968 Dec; ():39-42. PubMed ID: 4309347
[No Abstract] [Full Text] [Related]
17. Pathological lesions, including tumors, in rats after 4,4'-diaminodiphenylmethane and gamma-butyrolactone.
Schoental R
Isr J Med Sci; 1968; 4(6):1146-58. PubMed ID: 4306501
[No Abstract] [Full Text] [Related]
18. Kinetics of induction and growth of precancerous liver-cell foci, and liver tumour formation by diethylnitrosamine in the rat.
Scherer E; Emmelot P
Eur J Cancer (1965); 1975 Oct; 11(10):689-96. PubMed ID: 173556
[No Abstract] [Full Text] [Related]
19. Comparative enhancing effects of phenobarbital, amobarbital, diphenylhydantoin, and dichlorodiphenyltrichloroethane on 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat.
Peraino C; Fry RJ; Staffeldt E; Christopher JP
Cancer Res; 1975 Oct; 35(10):2884-90. PubMed ID: 1157054
[TBL] [Abstract][Full Text] [Related]
20. A physiologically based pharmacodynamic analysis of hepatic foci within a medium-term liver bioassay using pentachlorobenzene as a promoter and diethylnitrosamine as an initiator.
Thomas RS; Conolly RB; Gustafson DL; Long ME; Benjamin SA; Yang RS
Toxicol Appl Pharmacol; 2000 Jul; 166(2):128-37. PubMed ID: 10896854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
